Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1959 1
1960 1
1963 1
1964 5
1965 2
1966 5
1967 3
1968 9
1969 8
1970 17
1971 50
1972 61
1973 53
1974 53
1975 52
1976 54
1977 52
1978 61
1979 81
1980 61
1981 60
1982 96
1983 93
1984 95
1985 141
1986 118
1987 159
1988 180
1989 228
1990 287
1991 309
1992 380
1993 517
1994 626
1995 817
1996 1018
1997 1172
1998 1232
1999 1498
2000 1765
2001 1958
2002 2070
2003 2055
2004 1981
2005 2260
2006 2251
2007 2583
2008 2757
2009 2784
2010 3191
2011 3438
2012 3654
2013 3758
2014 3951
2015 4144
2016 4332
2017 4414
2018 4486
2019 5007
2020 5501
2021 5969
2022 5337
2023 5198
2024 1053

Text availability

Article attribute

Article type

Publication date

Search Results

84,256 results

Results by year

Filters applied: . Clear all
Page 1
Long-term complications after hematopoietic cell transplantation.
Majhail NS. Majhail NS. Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):220-227. doi: 10.1016/j.hemonc.2017.05.009. Epub 2017 Jun 13. Hematol Oncol Stem Cell Ther. 2017. PMID: 28641097 Free PMC article. Review.
The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT) survivors continues to increase. Among patients whose disease remains in remission for the first 2-5years after transplantation, it is estimated that approximately 80- …
The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT) survivors continues to increase. A …
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.
Gyurkocza B, Sandmaier BM. Gyurkocza B, et al. Blood. 2014 Jul 17;124(3):344-53. doi: 10.1182/blood-2014-02-514778. Epub 2014 Jun 9. Blood. 2014. PMID: 24914142 Free PMC article. Review.
An essential component of allogeneic and autologous hematopoietic cell transplantation (HCT) is the conditioning regimen administered before the hematopoietic cell infusion. ...
An essential component of allogeneic and autologous hematopoietic cell transplantation (HCT) is the conditioning regime …
Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Saad A, de Lima M, Anand S, Bhatt VR, Bookout R, Chen G, Couriel D, Di Stasi A, El-Jawahri A, Giralt S, Gutman J, Ho V, Horwitz M, Hsu J, Juckett M, Kharfan-Dabaja MA, Loren A, Meade J, Mielcarek M, Moreira J, Nakamura R, Nieto Y, Roddy J, Satyanarayana G, Schroeder M, Tan CR, Tzachanis D, Burn J, Pluchino L. Saad A, et al. J Natl Compr Canc Netw. 2020 May 1;18(5):599-634. doi: 10.6004/jnccn.2020.0021. J Natl Compr Canc Netw. 2020. PMID: 32519831
Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor cells into patients with hematologic disorders with the goal of re-establishing normal hematopoietic and immune function. ...Allogeneic HCT recipients may
Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor cells into patients w
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
van Lier YF, Vos J, Blom B, Hazenberg MD. van Lier YF, et al. Gut Microbes. 2023 Jan-Dec;15(1):2178805. doi: 10.1080/19490976.2023.2178805. Gut Microbes. 2023. PMID: 36794370 Free PMC article. Review.
Many patients with hematological malignancies, such as acute myeloid leukemia, receive an allogeneic hematopoietic cell transplantation (HCT) to cure their underlying condition. ...At present, manipulation of the microbiome for example, via dietary interventi …
Many patients with hematological malignancies, such as acute myeloid leukemia, receive an allogeneic hematopoietic cell tra
Maintenance Strategies After Hematopoietic Cell Transplantation.
Culos KA, Gatwood KS, Byrne M. Culos KA, et al. Pharmacotherapy. 2020 Aug;40(8):727-740. doi: 10.1002/phar.2407. Epub 2020 May 19. Pharmacotherapy. 2020. PMID: 32343426 Review.
Hematopoietic cell transplantation (HCT) is an essential component of potentially curative therapy for patients with hematologic malignancies. High-dose chemotherapy with autologous (auto) stem cell rescue is used to overcome chemoresistance in
Hematopoietic cell transplantation (HCT) is an essential component of potentially curative therapy for patients with he
Allogeneic hematopoietic cell transplantation; the current renaissance.
Copelan EA, Chojecki A, Lazarus HM, Avalos BR. Copelan EA, et al. Blood Rev. 2019 Mar;34:34-44. doi: 10.1016/j.blre.2018.11.001. Epub 2018 Nov 8. Blood Rev. 2019. PMID: 30467067 Review.
Allogeneic hematopoietic cell transplantation (HCT) provides the best chance for cure for many patients with malignant and nonmalignant hematologic disorders. ...
Allogeneic hematopoietic cell transplantation (HCT) provides the best chance for cure for many patients with malignant …
Review of Haploidentical Hematopoietic Cell Transplantation.
Khan MA, Bashir Q, Chaudhry QU, Ahmed P, Satti TM, Mahmood SK. Khan MA, et al. J Glob Oncol. 2018 Dec;4:1-13. doi: 10.1200/JGO.18.00130. J Glob Oncol. 2018. PMID: 30521413 Free PMC article. Review.
Use of haploidentical (haplo) donors for hematopoietic cell transplantation (HCT) has significantly increased in the last decade. The major advantage with this strategy is universal availability and faster acquisition of the donor, along with affordability an …
Use of haploidentical (haplo) donors for hematopoietic cell transplantation (HCT) has significantly increased in the la …
Managing Survivorship after Hematopoietic Cell Transplantation.
Khera N. Khera N. Curr Hematol Malig Rep. 2023 Jun;18(3):75-82. doi: 10.1007/s11899-023-00694-8. Epub 2023 Mar 30. Curr Hematol Malig Rep. 2023. PMID: 36995660 Free PMC article. Review.
PURPOSE OF REVIEW: With improvement in survival after hematopoietic cell transplantation (HCT), it has become important to focus on the late complications experienced by the survivors that may lead to late mortality and morbidity to be able to provide patient …
PURPOSE OF REVIEW: With improvement in survival after hematopoietic cell transplantation (HCT), it has become important …
Immune regulation in hematopoietic cell transplantation.
Negrin RS. Negrin RS. Bone Marrow Transplant. 2019 Aug;54(Suppl 2):765-768. doi: 10.1038/s41409-019-0600-7. Bone Marrow Transplant. 2019. PMID: 31431709 Review.
These immune effects have direct relevance in the setting of allogeneic hematopoietic cell transplantation (HCT), principally for the control of aberrant immune reactions, such as graft-versus-host disease (GVHD). ...Interestingly, there are critical interact …
These immune effects have direct relevance in the setting of allogeneic hematopoietic cell transplantation (HCT), princ …
84,256 results
You have reached the last available page of results. Please see the User Guide for more information.